Get started
Author

Valeria B. Saparova

Observed names: V. B. Saparova, V.B. Saparova, Valeria Saparova, В. Б. Сапарова, Сапарова В.Б.
ORCID: 0000-0002-8445-1129
Observed ORCID: 0000-0002-8445-1129
OpenAlex ID: A5040457645
Toxicity Patterns of Clinically Relevant Metal Oxide Nanoparticles
2019 · Anna F. Fakhardo, Elizaveta I. Anastasova, et al. · ACS Applied Bio Materials · 33
The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug
2025 · I. A. Lugovik, A. V. Babina, et al. · Drug development & registration · 13
PDF
Physiology and pharmacology of glucagon-like peptide-1 receptor
2024 · D. V. Kurkin, D. A. Bakulin, et al. · Pharmacy & Pharmacology · 11
PDF
Comparability of biosimilar romiplostim with originator: Protein characterization, animal pharmacodynamics and pharmacokinetics
2023 · Anna N. Arefeva, Igor E. Makarenko, et al. · Biologicals · 7
Optimal choice method of detection of the viability of cell cultures for tests on proliferation and cytotoxicity
2021 · A.N. Afanaseva, V.B. Saparova, et al. · Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science) · 7
Fixed ratio combinations GLP-1RA and basal insulin: literature review
2024 · D. V. Kurkin, D. A. Bakulin, et al. · Problems of Endocrinology · 4
PDF
A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers
2023 · Igor Makarenko, Artem Dorotenko, et al. · Pharmacology Research & Perspectives · 4
PDF
Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use
2023 · D. V. Kurkin, D. A. Bakulin, et al. · Pharmacy & Pharmacology · 4
Modern Concepts of the Pathogenesis of Type 2 Diabetes Mellitus
2022 · D.V. Kurkin, E.I. Morkovin, et al. · Journal of Volgograd State Medical University · 4
PDF
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity
2024 · Igor Makarenko, Aleksandr Petrov, et al. · Clinical Pharmacology in Drug Development · 2
Physicochemical and Functional Characterization of Medicinal Product Rinsulin® R
2023 · A. V. Babina, R. V. Drai, et al. · Drug development & registration · 2
PDF
Experimental Validation of an In Vitro Method for Assessing Insulin-Dependent Glucose Uptake
2022 · A. N. Afanasyeva, V. B. Saparova, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 2
PDF
Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar
2025 · Anait L. Melikyan, Ekaterina A. Protsenko, et al. · eJHaem · 1
PDF
Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay
2025 · Denis V. Kurkin, Dmitry A. Bakulin, et al. · Biomedicines · 1
PDF
Development of therapeutic peptide producers based on Escherichia coli BL21 and their cultivation technology
2025 · Z. R. Khasanshina, I. A. Kornakov, et al. · Drug development & registration · 1
PDF
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia
2024 · Aleksandr Petrov, Igor Makarenko, et al. · Clinical Pharmacology in Drug Development · 1
PDF
Experimental Validation a Method for Assessing Neutralizing Antibodies of Romiplostim in Human Plasma
2024 · A. N. Afanaseva, V. B. Saparova, et al. · Drug development & registration · 1
PDF
Comparative investigation of the efficacy of Cortexin®, Pineamine®, levilimab, adalimumab, and dexamethasone on cytokine storm models
2021 · A.V. Kalatanova, E.I. Trofimets, et al. · Farmaciya (Pharmacy) · 1
Physicochemical and biological characterization of the medicinal product RinLis®
2026 · S. S. Arutyunyan, R. V. Drai, et al. · Drug development & registration
PDF
Experience in validating a method for assessing GLP-1R receptor activation in vitro upon stimulation with tirzepatide
2026 · A. N. Afanaseva, V. B. Saparova, et al. · Drug development & registration
PDF
Erratum: "The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug"
2026 · I. A. Lugovik, A. V. Babina, et al. · Drug development & registration
PDF
Development, validation, and application of a method for assessing the viability of Escherichia coli for flow cytometry
2026 · A. S. Kazakova, A. N. Afanaseva, et al. · Drug development & registration
PDF
Development of a Method for Assessing Glp-1r Receptor on a Cell Line in Vitro Upon Stimulation With Tirzepatide in the “calcium Flux” Assay
2025 · D.O. Ermolaeva, V.B. Saparova, et al. · Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов (OpenBio)
PDF
Validation of a Method for Assessing Glp-1r Receptor in Vitro Upon Stimulation With Tirzepatide
2025 · D.O. Ermolaeva, V.B. Saparova, et al. · Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов (OpenBio)
PDF
Разработка и валидация методики оценки жизнеспособности Escherichia coli с помощью проточной цитометрии
2024 · А. С. Казакова, А. Н. Афанасьева, et al. · Biotekhnologiya
Works count: 28
Citation count: 99
H-index: 5
I10-index: 3
Year
Topic
Type